Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk (TIERRA)

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: April 1, 2009
Last updated: February 12, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2008
  Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)